ASHP therapeutic position statement on the use of second-generation antipsychotic medications in the treatment of adults with psychotic disorders.
Noel
Jason M
JM
University of Maryland School of Pharmacy, Baltimore 21201, USA. jnoel@rx.umaryland.edu
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D016903:Drug Monitoring; D004409:Dyskinesia, Drug-Induced; D006801:Humans; D010818:Practice Patterns, Physicians'; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D012957:Societies, Pharmaceutical; D014481:United States
D014150:Antipsychotic Agents